. 2014 Dec 1;9(12):e112925. doi: 10.1371/journal.pone.0112925

Table 3. Clinical EAE in actively immunized mice treated with α-NETA^a.

Treatment group	Mean day of onset (SEM)^b	Incidence by day 27 post-immunization
vehicle	10.6 (0.7)	24/25 (96%)
α-NETA	19.6 (1.2)^***	17/24 (71%)^*

Data are pooled from three independent experiments with each experiment consisting of 7–10 mice per group.

*p<0.05, as determined by Fisher's exact test;

***p<0.001, as determined by Mann-Whitney U test.

Determined only for animals that developed EAE.

Table 3. Clinical EAE in actively immunized mice treated with α-NETAa.